Cancer Treat Commun. 2015;4:174-181.
Experience with targeted next generation sequencing for the care of lung cancer: insights into promises and limitations of genomic oncology in day-to-day practice.
Rangachari D1, VanderLaan PA2, Le X1, Folch E3, Kent MS4, Gangadharan SP4, Majid A3, Haspel RL2, Joseph LJ2, Huberman MS1, Costa DB1.
ALK; EGFR; MET; Non-small-cell lung cancer; ROS1; adenocarcinoma; driver oncogene; genotype; next generation sequencing; squamous cell carcinomas
- [Available on 2016-01-01]